Enter to open, tab to navigate, enter to select
Ligand Pharmaceuticals Incorporated and Open Monoclonal Technology, Inc. merger
| December 17, 2015 • Private Acquisition Agreements • $178 million (subject to purchase price adjustment). |
End of Document
© 2024 Thomson Reuters. No claim to original U.S. Government Works.